Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.
暂无分享,去创建一个
Ekaterina Rogaeva | Tim-Rasmus Kiehl | T. Kiehl | L. Hazrati | A. Lang | A. Bassett | E. Rogaeva | N. Butcher | E. Chow | Anthony E Lang | Nancy J Butcher | Anne S Bassett | Lili-Naz Hazrati | Eva W C Chow
[1] R. Weksberg,et al. Clinical features of 78 adults with 22q11 deletion syndrome , 2005, American journal of medical genetics. Part A.
[2] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[3] Anthony-Samuel LaMantia,et al. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome , 2009, Proceedings of the National Academy of Sciences.
[4] K. Devriendt,et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. , 2011, The Journal of pediatrics.
[5] A. Bassett,et al. The co‐occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome , 2009, American journal of medical genetics. Part A.
[6] A. Singleton,et al. The genetics and neuropathology of Parkinson’s disease , 2012, Acta Neuropathologica.
[7] K. Teschke,et al. The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology. , 2003, Parkinsonism & related disorders.
[8] Jemma B. Wilk,et al. Copy Number Variation in Familial Parkinson Disease , 2011, PloS one.
[9] H. Adami,et al. Epidemiology and etiology of Parkinson’s disease: a review of the evidence , 2011, European Journal of Epidemiology.
[10] J. Lieberman,et al. A comprehensive analysis of 22q11 gene expression in the developing and adult brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] Paul Pavlidis,et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model , 2008, Nature Genetics.
[12] N. Shimizu,et al. Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in the Parkin gene in affected individuals , 1998, Annals of neurology.
[13] T. Dawson,et al. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Maraganore,et al. Childhood-onset schizophrenia associated with parkinsonism in a patient with a microdeletion of chromosome 22. , 1998, Mayo Clinic proceedings.
[15] A. Meyer-Lindenberg,et al. Striatal presynaptic dopamine in schizophrenia, Part I: meta-analysis of dopamine active transporter (DAT) density. , 2013, Schizophrenia bulletin.
[16] I. Cross,et al. A population study of chromosome 22q11 deletions in infancy , 1998, Archives of disease in childhood.
[17] R. Hilker,et al. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers , 2005, Annals of neurology.
[18] Sonja W. Scholz,et al. Genomewide SNP assay reveals mutations underlying Parkinson disease , 2008, Human mutation.
[19] Anne S. Bassett,et al. miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome , 2012, Front. Gene..
[20] A. Bassett,et al. Extracardiac features predicting 22q11.2 deletion syndrome in adult congenital heart disease. , 2008, International journal of cardiology.
[21] L. White,et al. Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease , 2012, Neurology.
[22] J. Husted,et al. Premature death in adults with 22q11.2 deletion syndrome , 2009, Journal of Medical Genetics.
[23] Paul J. Harrison. The neuropathological effects of antipsychotic drugs , 1999, Schizophrenia Research.
[24] Thomas Meitinger,et al. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.
[25] Janel O. Johnson,et al. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. , 2004, Archives of neurology.
[26] Paul J. Harrison. The neuropathology of schizophrenia , 2008 .
[27] C. Goetz,et al. An update expert opinion on management and research strategies in Parkinson's disease psychosis , 2011, Expert opinion on pharmacotherapy.
[28] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[29] P. S. St George-Hyslop,et al. LRRK2 gene in Parkinson disease , 2005, Neurology.
[30] S. Züchner,et al. A Rare Novel Deletion of the Tyrosine Hydroxylase Gene in Parkinson Disease , 2010, Human mutation.
[31] J. Lieberman,et al. Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes , 2008, Molecular and Cellular Neuroscience.
[32] S. Yim,et al. Comparative Genome Hybridization Array Analysis for Sporadic Parkinson’s Disease , 2008, The International journal of neuroscience.
[33] K. Marder,et al. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. , 2010, Archives of neurology.
[34] Ronak K. Kapadia,et al. Clinically detectable copy number variations in a Canadian catchment population of schizophrenia. , 2010, Journal of psychiatric research.
[35] Christian R. Marshall,et al. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome , 2008, Human molecular genetics.
[36] Stanislav S Zakharenko,et al. Age-Dependent MicroRNA Control of Synaptic Plasticity in 22q11 Deletion Syndrome and Schizophrenia , 2012, The Journal of Neuroscience.
[37] Norbert Gretz,et al. miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.
[38] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[39] J. Cummings,et al. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. , 2011, Brain : a journal of neurology.
[40] J. Dartigues,et al. Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort , 2012, Neurology.
[41] D J Mikulis,et al. Neuropathologic features in adults with 22q11.2 deletion syndrome. , 2009, Cerebral cortex.
[42] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[43] P. Heutink,et al. Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.